Publication | Open Access
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
61
Citations
17
References
2021
Year
In PPMS, effector B-cell depletion changed T-cell response toward a low inflammatory profile, resulting in decreased sNfL levels.
| Year | Citations | |
|---|---|---|
Page 1
Page 1